We partner with the media to inform the public of the global human crisis.
June 15, 2018Indivior Is Granted Temporary Restraining Order...
June 15, 2018Indivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy’s Launch “At-Risk”...
May 31, 2018Indivior Receives Subpoena from California Department of Insurance...
May 25, 2018Indivior Announces Regulatory Submission to Australia’s Therapeutic Goods Administration (TGA) for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence...
May 17, 2018Result of AGM...
Global Media Contacts
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline